Table 3. Changes in clinical outcome measures between pre- and post-treatment.
Variables | Experimental group | Control group |
---|---|---|
Δ FMA-LLparetic | 2.00 ± 2.79 | 3.00 ± 4.60 |
ΔBBS | 10.40 ± 8.25 | 10.80 ± 5.01 |
Δ6MWT (m) | 93.50 ± 56.28 | 118.50 ± 50.40 |
ΔK-MBI | 21.30 ± 15.13 | 27.90 ± 14.93 |
Values are mean ± standard deviation. FMA-LLparetic: paretic lower limb score of the Fugl-Meyer assessment; BBS: Berg balance test; 6MWT: 6-minute walk test; K-MBI: Korean version of the Modified Barthel Index